Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01880099 · ClinicalTrials.gov registry record · NA
A Study to Help People Quit Smoking.
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01880099 is a NA study that has completed, run by Yale University. The registered enrollment target is 60 participants.
The verdict
NCT01880099, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
You are invited to participate in a research study at the VA Connecticut Healthcare System (West Haven campus) that examines whether a medication called galantamine can improve your learning and memory, and also help you to quit smoking. You have been invited to participate because you currently smoke cigarettes, and want to quit smoking. If you are eligible and agree to be in the study, your participation will last for approximately 8 weeks. To determine if galantamine (8 or 16 mg) is superior to placebo a) in reducing smoking self-administration in a human laboratory model and b) improving abstinence rates at the end of 4 weeks of treatment.
Interventions
- DRUG placebo
- DRUG Galantamine 8mg
- DRUG Galantamine 16mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01880099
The ClinicalTrials.gov registry entry for NCT01880099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01880099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01880099 about?
NCT01880099 is a clinical study titled "A Study to Help People Quit Smoking.". You are invited to participate in a research study at the VA Connecticut Healthcare System (West Haven campus) that examines whether a medication called galantamine can improve your learning and memory, and also help you to quit smoking. You have been invited to participate because you currently smo...
What is the current status of trial NCT01880099?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01880099?
The interventions under investigation include: placebo (DRUG), Galantamine 8mg (DRUG), Galantamine 16mg (DRUG).
Who is sponsoring clinical trial NCT01880099?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.